GB0330049D0 - The treatment of neuropathic pain conditions - Google Patents

The treatment of neuropathic pain conditions

Info

Publication number
GB0330049D0
GB0330049D0 GBGB0330049.8A GB0330049A GB0330049D0 GB 0330049 D0 GB0330049 D0 GB 0330049D0 GB 0330049 A GB0330049 A GB 0330049A GB 0330049 D0 GB0330049 D0 GB 0330049D0
Authority
GB
United Kingdom
Prior art keywords
treatment
neuropathic pain
pain conditions
conditions
neuropathic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0330049.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sosei R&D Ltd
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Priority to GBGB0330049.8A priority Critical patent/GB0330049D0/en
Publication of GB0330049D0 publication Critical patent/GB0330049D0/en
Priority to PCT/GB2004/005408 priority patent/WO2005060957A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/5545Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0330049.8A 2003-12-24 2003-12-24 The treatment of neuropathic pain conditions Ceased GB0330049D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0330049.8A GB0330049D0 (en) 2003-12-24 2003-12-24 The treatment of neuropathic pain conditions
PCT/GB2004/005408 WO2005060957A1 (fr) 2003-12-24 2004-12-24 Preparation de nefopam et utilisation de cette preparation pour le traitement de la douleur

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0330049.8A GB0330049D0 (en) 2003-12-24 2003-12-24 The treatment of neuropathic pain conditions

Publications (1)

Publication Number Publication Date
GB0330049D0 true GB0330049D0 (en) 2004-02-04

Family

ID=31503197

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0330049.8A Ceased GB0330049D0 (en) 2003-12-24 2003-12-24 The treatment of neuropathic pain conditions

Country Status (2)

Country Link
GB (1) GB0330049D0 (fr)
WO (1) WO2005060957A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2937553B1 (fr) * 2008-10-29 2011-01-07 Biocodex Combinaison synergique de composes analgesiques
FR2940911B1 (fr) * 2009-01-13 2012-09-21 Philippe Perovitch Formulation pour l'administration par voie trans-muqueuse buccale de molecules antalgiques et/ou anti-spasmodiques
WO2011072394A1 (fr) 2009-12-15 2011-06-23 The Hospital For Sick Children Procédé de traitement de cicatrices et de troubles à médiation par la β-caténine à l'aide de composés du néfopam
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
EP3679927A1 (fr) * 2019-01-14 2020-07-15 APTYS Pharmaceuticals SAS Procédé de fabrication d'une composition pharmaceutique comprenant du néfopam et de l'acétaminophène et composition pharmaceutique ainsi obtenue

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
GB0213869D0 (en) * 2002-06-17 2002-07-31 Arakis Ltd The treatment of pain

Also Published As

Publication number Publication date
WO2005060957A1 (fr) 2005-07-07

Similar Documents

Publication Publication Date Title
GB2415378B (en) Treatment of neurodegenerative conditions
GB2422373B (en) Treatment of neurodegenerative conditions
EP1617844A4 (fr) Traitement d'affections neurologiques
GB0213869D0 (en) The treatment of pain
GB0211295D0 (en) Treatment of pain
EP1653982A4 (fr) Methode servant a traiter la mauvaise haleine
GB0330049D0 (en) The treatment of neuropathic pain conditions
GB0300783D0 (en) Treatment of neurodegenerative conditions
HK1087026A1 (en) Use of indazole derivtives for the treatment of neuropathic pain
EP1687275A4 (fr) Composes de pyridin-4-ylamine convenant pour le traitement de la douleur neuropathique
AU2003259074A8 (en) Gal3 antagonists for the treatment of neuropathic pain
EP1691776A4 (fr) Traitement du sida
GB0300428D0 (en) Medical treatment
IL164951A0 (en) The treatment of pain with lfendropil
HK1087027A1 (en) Use of 2H-Ä1, 3Ü-oxazinoÄ3,2-AÜindole derivatives for the treatment of neuropathic pain
GB0322015D0 (en) The treatment of neuropathic pain conditions
GB2409655B (en) Treatment of fluids
GB0325957D0 (en) The treatment of pain
GB0219706D0 (en) The treatment of neuropathic pain
GB0327975D0 (en) Methods of treatment
GB0322014D0 (en) The treatment of pain
GB0211297D0 (en) Pain treatment
GB0213870D0 (en) The treatment of pain conditions
GB0216978D0 (en) The treatment of pain
GB0418556D0 (en) The treatment of pain

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)